UW Awarded DREAMS Innovation Challenge to Bring PrEP to Adolescents in Kenya

The University of Washington is one of 56 DREAMS Innovation Challenge winners* announced on Monday by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR); Janssen Pharmaceutica NV (Janssen), one of the Janssen pharmaceutical companies of Johnson & Johnson; and ViiV Healthcare.

NewsBeat: Vaginal Ring Better against HIV than Initial Results Showed

New data analyses finds that a monthly vaginal ring containing an antiretroviral drug called dapivirine can cut women’s HIV risk by more than half and, in some, by 75 percent or more.

One of the researchers, Jared Baeten, a University of Washington professor of epidemiology, medicine and global health, presented the results Tuesday at the AIDS 2016 conference in Durban, South Africa.

UW Daily: Turning the tide on HIV

By Chelsea Gish

The ASPIRE trial and The Ring Study, two large scale clinical trials, have found that microbicides can safely reduce the risk of new HIV infections in women.

A microbicide is any compound capable of destroying microbes and infectious agents. Recently, this method of prevention has become particularly relevant in reducing the transmission of HIV when applied to the vaginal or rectal region as a topical gel.


NewsBeat: Microbicide Reduces Women's HIV Risk in Large-Scale Trial

By Lisa Rossi

Two large clinical trials have found that a microbicide prevention method can safely help reduce new HIV infections in women.

Results of the ASPIRE trial, which enrolled more than 2,600 women in Africa, were announced today at the Conference on Retroviruses and Opportunistic Infections in Boston. The results also will be published online in the New England Journal of Medicine.

Jared Baeten Named Vice Chair of Department

We are delighted to announce that Jared Baeten, MD, PhD has agreed to serve as Vice Chair for the Department of Global Health. Dr. Baeten, who is also a Professor in the Departments of Epidemiology and Medicine, has been conducting HIV- and STD-related research since 1997 and is widely respected for his leadership of clinical trials of interventions to prevent HIV transmission. As Vice Chair Dr.